Edward G. Corley

Statistics

Publications

Citations

2.2K

H-Index

Active since

1985

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Merck Biopharma Co., Ltd. (Japan)

DuPont (United States)

Edward G. Corley is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in chemistry, natural sciences, and organic chemistry.

Publications per year

1985–2010

Publications

Practical Route to a New Class of LTD<sub>4</sub> Receptor Antagonists

Robert D. Larsen, Edward G. Corley, Anthony O. King et al. · The Journal of Organic Chemistry · 1996 · 225 citations

Natural Sciences, Chemistry, Medicinal Chemistry +6

Practical Asymmetric Synthesis of Efavirenz (DMP 266), an HIV-1 Reverse Transcriptase Inhibitor

Michael E. Pierce, Rodney L. Parsons, Lilian Radesca et al. · The Journal of Organic Chemistry · 1998 · 215 citations

Pharmacy, Chemistry, Medicinal Chemistry +16

A practical process for the preparation of tetrahydro-1-methyl-3,3-diphenyl-1H,3H-pyrrolo[1,2-c][1,3,2]oxazaborole-borane. A highly enantioselective stoichiometric and catalytic reducing agent

David J. Mathre, Andrew S. Thompson, Alan W. Douglas et al. · The Journal of Organic Chemistry · 1993 · 209 citations

Natural Sciences, Chemistry, Catalysis +10

Efficient Synthesis of Losartan, A Nonpeptide Angiotensin II Receptor Antagonist

Robert D. Larsen, Anthony O. King, Cheng‐Yu Chen et al. · The Journal of Organic Chemistry · 1994 · 193 citations

Pharmacy, Medicinal Chemistry, Pharmacology +8

Lithium Ephedrate-Mediated Addition of a Lithium Acetylide to a Ketone: Solution Structures and Relative Reactivities of Mixed Aggregates Underlying the High Enantioselectivities

Andrew S. Thompson, Edward G. Corley, Martha Huntington et al. · Journal of the American Chemical Society · 1998 · 162 citations

Natural Sciences, Chemistry, Catalysis +10

1–5 of 31